TY - JOUR
T1 - ApoE ε4 allele related alterations in hippocampal connectivity in Early Alzheimer’s disease support memory performance
AU - Alzheimer's Disease Neuroimaging Initiative
AU - de Marco, Matteo
AU - Vallelunga, Annamaria
AU - Meneghello, Francesca
AU - Varma, Susheel
AU - Frangi, Alejandro F.
AU - Venneri, Annalena
N1 - Funding Information:
The BioBank of Rare and Neurorehabilitative Diseases, IRCCS Fondazione Ospedale San Camillo provided us with specimens. The authors thank Cristina Pilosio, Jessica Rigon, Francesca Bevilacqua, Davide Duzzi, Elisabetta Tasca, and all personnel in the MRI unit of the IRCCS Fondazione Ospedale San Camillo in Venice, Italy for their various contributions to patient assessment, imaging acquisitions and planning of image analyses. The authors also thank Leandro Beltrachini and Ernesto Coto for their help with ADNI image processing and modelling. As part of the STEPS procedures of hippocampal segmentation, the GPU card used for this research was donated by the NVIDIA Corporation. This study has been supported by grant No. 42/RF-2010-2321718 from the Italian Ministry of Health to AV. MDM and SV are employed through funding from the European Union Seventh Framework Programme (FP7/2007 - 2013) under grant agreement no. 601055, VPH-DARE@IT to AV and AF. For the purpose of post hoc analyses, data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol- Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Euro- Immun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institute of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institute of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer’s Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.
Publisher Copyright:
© 2017 Bentham Science Publishers.
PY - 2017
Y1 - 2017
N2 - Background: Whether the presence of the Apolipoprotein E ε4 allele modulates hippocampal connectivity networks in abnormal ageing has yet to be fully clarified. Objective: Allele-dependent differences in this pattern of functional connectivity were investigated in patients with very mild neurodegeneration of the Alzheimer’s type, carriers and non-carriers of the ε4 allele. Method: A seed-based connectivity approach was used. The two groups were similar in demographics, volumetric measures of brain structure, and cognitive profiles. Results: ε4-carriers had increased connectivity between the seed area in the left hippocampus and 1) a left insular/lateral prefrontal region and 2) the contralateral right parietal cortex. Moreover, hippocampus- to-parietal connectivity in the group of ε4 carriers was positively associated with memory performance, indicating that the between-group difference reflects compensatory processes. Retrospective analyses of functional connectivity based on patients from the ADNI initiative confirmed this pattern. Conclusion: We suggest that increased connectivity with areas external to the Default Mode Network (DMN) reflects both compensatory recruitment of additional areas, and pathological interwining between the DMN and the salience network as part of a global ε4-dependent circuital disruption. These differences indicate that the ε4 allele is associated with a more profound degree of DMN network breakdown even in the prodromal stage of neurodegeneration.
AB - Background: Whether the presence of the Apolipoprotein E ε4 allele modulates hippocampal connectivity networks in abnormal ageing has yet to be fully clarified. Objective: Allele-dependent differences in this pattern of functional connectivity were investigated in patients with very mild neurodegeneration of the Alzheimer’s type, carriers and non-carriers of the ε4 allele. Method: A seed-based connectivity approach was used. The two groups were similar in demographics, volumetric measures of brain structure, and cognitive profiles. Results: ε4-carriers had increased connectivity between the seed area in the left hippocampus and 1) a left insular/lateral prefrontal region and 2) the contralateral right parietal cortex. Moreover, hippocampus- to-parietal connectivity in the group of ε4 carriers was positively associated with memory performance, indicating that the between-group difference reflects compensatory processes. Retrospective analyses of functional connectivity based on patients from the ADNI initiative confirmed this pattern. Conclusion: We suggest that increased connectivity with areas external to the Default Mode Network (DMN) reflects both compensatory recruitment of additional areas, and pathological interwining between the DMN and the salience network as part of a global ε4-dependent circuital disruption. These differences indicate that the ε4 allele is associated with a more profound degree of DMN network breakdown even in the prodromal stage of neurodegeneration.
KW - Alzheimer’s disease
KW - disinhibition hypothesis
KW - functional connectivity
KW - hippocampus
KW - network disruption
KW - posterior cingulate
UR - http://www.scopus.com/inward/record.url?scp=85025087460&partnerID=8YFLogxK
U2 - 10.2174/1567205014666170206113528
DO - 10.2174/1567205014666170206113528
M3 - Article
C2 - 28176662
AN - SCOPUS:85025087460
SN - 1567-2050
VL - 14
SP - 766
EP - 777
JO - Current Alzheimer Research
JF - Current Alzheimer Research
IS - 7
ER -